Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ADMS

Adamas Pharmaceuticals (ADMS) Stock Price, News & Analysis

Adamas Pharmaceuticals logo

About Adamas Pharmaceuticals Stock (NASDAQ:ADMS)

Advanced Chart

Key Stats

Today's Range
$8.22
$8.22
50-Day Range
$7.97
$8.23
52-Week Range
$4.02
$9.15
Volume
N/A
Average Volume
692,487 shs
Market Capitalization
$376.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ADMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Adamas Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ADMS Stock News Headlines

The Coin That Could Define Trump’s Crypto Presidency
When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”
Adamas One Corp (JEWL)
See More Headlines

ADMS Stock Analysis - Frequently Asked Questions

Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) posted its earnings results on Thursday, November, 11th. The specialty pharmaceutical company reported ($0.43) EPS for the quarter, missing the consensus estimate of ($0.22) by $0.21. The specialty pharmaceutical company had revenue of $25.90 million for the quarter, compared to analysts' expectations of $25.07 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that Adamas Pharmaceuticals investors own include Rite Aid (RAD), VBI Vaccines (VBIV), Amarin (AMRN), Agile Therapeutics (AGRX), Dynavax Technologies (DVAX), TherapeuticsMD (TXMD) and Exelixis (EXEL).

Company Calendar

Last Earnings
11/11/2021
Today
8/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ADMS
CIK
1328143
Employees
138
Year Founded
2002

Profitability

EPS (Trailing Twelve Months)
($1.70)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$57.40 million
Net Margins
-71.11%
Pretax Margin
-71.11%
Return on Equity
N/A
Return on Assets
-42.96%

Debt

Debt-to-Equity Ratio
21.25
Current Ratio
4.53
Quick Ratio
4.17

Sales & Book Value

Annual Sales
$74.46 million
Price / Sales
5.05
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.47) per share
Price / Book
-17.49

Miscellaneous

Outstanding Shares
45,787,000
Free Float
37,133,000
Market Cap
$376.37 million
Optionable
Optionable
Beta
2.82

Social Links

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:ADMS) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners